Riccardo Levato

Utrecht University is offering a PhD position in Biofabrication technologies for in situ control of cellular environments, focusing on advanced bioprinting and regenerative medicine. The successful candidate will join the Malda and Levato research groups within the Regenerative Medicine Center Utrecht, working on cutting-edge bioprinting technologies such as light-based volumetric and multiphoton printing, as well as magnetic and acoustic field-based techniques. The research aims to control cells and materials within assembled and in vivo developing tissues, with a key focus on cardiac and renal tissue engineering. The project is part of the DRIVE-RM consortium, providing opportunities to collaborate with a multidisciplinary network of 24 PhD candidates across Utrecht University, UMC Utrecht, Hubrecht Institute, Maastricht University, and TU Eindhoven. The research will involve developing organoid culture and biofabrication techniques, contributing to developmental biology and regenerative medicine. The candidate will have access to state-of-the-art facilities, including the Utrecht Biofabrication Facility, and will work in a collaborative, multidisciplinary team of veterinarians, clinicians, material scientists, biologists, and engineers. Applicants must hold an MSc degree in biomedical engineering, biology, biotechnology, bioengineering, materials science, or a related field, with proven expertise in bioprinting technologies and cell/tissue culture. Proficiency in English and strong communication and collaboration skills are required. The position offers a four-year contract (one year initially, extendable), a gross monthly salary between €3,059 and €3,881, 8% holiday pay, 8.3% year-end bonus, pension scheme, and flexible employment terms. Utrecht University values diversity and inclusion and encourages applicants from all backgrounds. To apply, submit your CV and motivation letter via the Utrecht University job portal before 11 February 2026. For more information, contact Riccardo Levato or Jos Malda by email. This is an excellent opportunity for candidates passionate about biofabrication, bioprinting, and regenerative medicine to contribute to innovative research in a leading academic environment.

Utrecht University / UMC Utrecht is advertising a fully funded postdoc in organoid biology and advanced human-relevant tissue models within the biofabrication team at Regenerative Medicine Utrecht. The project focuses on building next-generation human-relevant liver tissues using volumetric bioprinting , with applications in pharmaceutical research and pre-clinical drug screening. The work is embedded in the EIC Transition project REVOLV (REliable animal-free and high-throughput VOLumetric bioprinting of functional 3D assays), funded by the European Innovation Council and SMEs Executive Agency (EISMEA). Research themes include 3D culture , organoid systems , advanced in vitro models , regenerative medicine , and new approach methodologies (NAMs) for alternatives to animal experimentation. The post offers collaboration with international partners, including Readily3D, and is described as part of an ambitious, international research program with strong publication and patent potential. Eligibility highlights: experience with organoid systems, 3D culture, and advanced in vitro models is specifically requested. The post is aimed at a postdoctoral researcher interested in biofabrication, tissue engineering, and translational biomedical research. Deadline: apply before 2026-06-02 . How to apply: applications are accepted only via the official online application link provided in the post.

Utrecht University is advertising a PhD candidate position in biofabrication, optogenetics, synthetic biology, bioprinting, organoid biology, and vascularization within the Levato research group at the Regenerative Medicine Center Utrecht. The project is ERC-funded and focuses on developing new strategies to control vascular cell behavior in complex 3D human tissues and organoid-based engineered tissues, with an initial application in diabetes research . The work combines engineered stem cells, synthetic biology tools, ultra-fast light-based volumetric bioprinting, and advanced tissue engineering approaches to capture and understand healthy and diseased vascular conditions. Applicants should have a Master’s degree in biotechnology, synthetic biology, biology, biomedical engineering, or a related field. Experience in cell engineering, molecular biology, and bioengineering is required, while optogenetics, organoids, gene editing, vascular cell biology, hydrogels, and light-based bioprinting are advantageous. Strong English skills are required. The position is based in Utrecht, Netherlands, at Utrecht University’s Faculty of Veterinary Medicine / Department of Clinical Sciences, with collaboration across an international multidisciplinary network and the OMBION Center for Animal-Free Biomedical Translation. The appointment is initially for 12 months and may be extended up to four years to complete the doctorate. Funding includes a gross monthly salary of €3,059 to €3,881 for full-time employment, plus holiday pay, year-end bonus, pension, and other employment benefits. The application deadline is 23 June 2026 . To apply, submit a CV and motivation letter through the Utrecht University portal. The post also requests contact details for two academic referees.